Related content

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite

P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SARFuture Perspective for Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 22, 2016-06 ,pp. : 2484-2508

Bentham Science Publishers

Access to resources Recommend Favorite

Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

By Woodland Cindy   Koren Gideon   Wainer Irving W   Batist Gerry   Ito Shinya  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 8, 2003-08 ,pp. : 800-805

NRC Research Press

Access to resources Recommend Favorite

Dihidro-&bgr;-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-09 ,pp. : 3125-3139

Bentham Science Publishers

Access to resources Recommend Favorite

Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives

By Hayashi1 M.   Koike2 K.   Rho14 M-C.   Kuwano3 M.   Kishiye2 T.   Komiyama1 K.  

Anti-Cancer Drug Design, Vol. 16, Iss. 4, 2001-08 ,pp. : 255-260

Cognizant Communication Corporation

Access to resources Recommend Favorite